Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality
Artificial Organs · 2024
DOI: 10.1111/aor.14820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Doug A Gouchoe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Perfusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, HRSA HHS, Health Resources and Services Administration.
Abstract (Originalsprache)
Background
The purpose of this study was to identify the association of increasing ischemic times in recipients who receive lungs evaluated by ex vivo lung perfusion (EVLP) and their association with outcomes following lung transplantation.
Methods
Lung transplant recipients who received an allograft evaluated by EVLP were identified from the United Network for Organ Sharing (UNOS) Database from 2016–2023. Recipients were stratified into three groups based on total ischemic time (TOT): short TOT (STOT, 0 to to 0.05 for both). On multivariable analysis, ischemic time was not associated with increased mortality whereas increasing recipient age, preoperative ECMO use and donation after circulatory death donors were ( p < 0.05 for all).
Conclusions
If EVLP technology is available, under certain circumstances, surgeons should not be dissuaded from using an allograft with extended ischemic time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- COPPER Laboratory, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
ORCID-Profile: Doug A Gouchoe, Matthew C Henn, Asvin M Ganapathi
Förderung
- NHLBI NIH HHS
- HRSA HHS
- Health Resources and Services Administration
Zitieren
APA
Gouchoe, D. A., Satija, D., Cui, E. Y., Aly, A., Henn, M. C., Choi, K., Nunley, D., Mokadam, N. A., Ganapathi, A. M., & Whitson, B. A. (2024). Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality. Artificial Organs. https://doi.org/10.1111/aor.14820
Vancouver
Gouchoe DA, Satija D, Cui EY, Aly A, Henn MC, Choi K, et al. Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality. Artificial Organs. 2024. doi:10.1111/aor.14820
BibTeX
@article{Gouchoe2024,
author = {Gouchoe, Doug A and Satija, Divyaam and Cui, Ervin Y and Aly, Ahmed and Henn, Matthew C and Choi, Kukbin and Nunley, David and Mokadam, Nahush A and Ganapathi, Asvin M and Whitson, Bryan A},
title = {Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality},
journal = {Artificial Organs},
year = {2024},
doi = {10.1111/aor.14820}
}
EUVIMED